FIELD: medicine.
SUBSTANCE: invention can be used for diagnosing severe preeclampsia in pregnant women. Method involves the peripheral venous immunoassay during 22-37 weeks of pregnancy. There is determined a relative content of CD62L + cells in the population of neutrophils and if its value is equal to or less than 57 %, severe preeclampsia is diagnosed.
EFFECT: use of the invention enables diagnosing of preeclampsia regardless of presence in a woman of chronic arterial hypertension.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR PREECLAMPSIA IN PREGNANT WOMEN SUFFERING CHRONIC ARTERIAL HYPERTENSION | 2014 |
|
RU2561060C1 |
| METHOD FOR THE DIAGNOSIS OF PREECLAMPSIA | 2019 |
|
RU2721688C1 |
| METHOD OF DIAGNOSTICS OF PREECLAMPSIA ATTACHMENT IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2016 |
|
RU2652447C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
| METHOD FOR DIAGNOSING SEVERITY OF PREECLAMPSIA WITH UNDERLYING CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2815220C1 |
| METHOD OF DIAGNOSTICS OF SEVERITY OF PRE-ECLAMPSIA ON THE BACKGROUND OF CHRONIC ARTERIAL HYPERTENSION IN PREGNANT WOMEN | 2023 |
|
RU2804645C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF MODERATE PREECLAMPSIA | 2020 |
|
RU2752715C1 |
| METHOD FOR PREECLAMPSIA SEVERITY ASSESSMENT BY RELATIVE CONTENT OF CD16+ MONOCYTES IN PERIPHERAL BLOOD OF PREGNANT WOMEN | 2019 |
|
RU2712228C1 |
| DIAGNOSTIC TECHNIQUE OF PREECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2012 |
|
RU2483311C1 |
| METHOD FOR DIAGNOSING SEVERE GESTOSIS FORMS | 2003 |
|
RU2259568C2 |
